Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 158

1.

An admission bioclinical score to predict 1-year outcomes in patients undergoing aneurysm coiling.

Degos V, Apfel CC, Sanchez P, Colonne C, Renuit I, Clarençon F, Nouet A, Boch AL, Pourmohamad T, Kim H, Gourraud PA, Young WL, Puybasset L.

Stroke. 2012 May;43(5):1253-9. doi: 10.1161/STROKEAHA.111.638197. Epub 2012 Feb 23.

2.

S100B as an additional prognostic marker in subarachnoid aneurysmal hemorrhage.

Sanchez-Peña P, Pereira AR, Sourour NA, Biondi A, Lejean L, Colonne C, Boch AL, Al Hawari M, Abdennour L, Puybasset L.

Crit Care Med. 2008 Aug;36(8):2267-73. doi: 10.1097/CCM.0b013e3181809750.

PMID:
18596638
3.

Operative complications and differences in outcome after clipping and coiling of ruptured intracranial aneurysms.

Ayling OG, Ibrahim GM, Drake B, Torner JC, Macdonald RL.

J Neurosurg. 2015 Sep;123(3):621-8. doi: 10.3171/2014.11.JNS141607. Epub 2015 Jun 5.

PMID:
26047409
4.

Prognosis value of plasma S100B protein levels after subarachnoid aneurysmal hemorrhage.

Weiss N, Sanchez-Peña P, Roche S, Beaudeux JL, Colonne C, Coriat P, Puybasset L.

Anesthesiology. 2006 Apr;104(4):658-66. Erratum in: Anesthesiology. 2008 Apr;108(4):767.

PMID:
16571959
5.

Acute postoperative neurological deterioration associated with surgery for ruptured intracranial aneurysm: incidence, predictors, and outcomes.

Mahaney KB, Todd MM, Bayman EO, Torner JC; IHAST Investigators.

J Neurosurg. 2012 Jun;116(6):1267-78. doi: 10.3171/2012.1.JNS111277. Epub 2012 Mar 9.

PMID:
22404668
6.

Which treatment modality is more injurious to the brain in patients with subarachnoid hemorrhage? Degree of brain damage assessed by serum S100 protein after aneurysm clipping or coiling.

Shim JH, Yoon SM, Bae HG, Yun IG, Shim JJ, Lee KS, Doh JW.

Cerebrovasc Dis. 2012;34(1):38-47. doi: 10.1159/000338786. Epub 2012 Jun 29.

PMID:
22759541
7.

A multiparameter panel method for outcome prediction following aneurysmal subarachnoid hemorrhage.

Turck N, Vutskits L, Sanchez-Pena P, Robin X, Hainard A, Gex-Fabry M, Fouda C, Bassem H, Mueller M, Lisacek F, Puybasset L, Sanchez JC.

Intensive Care Med. 2010 Jan;36(1):107-15. doi: 10.1007/s00134-009-1641-y. Epub 2009 Sep 17.

PMID:
19760205
8.
9.

Plasma visfatin, a possible prognostic marker in aneurysmal subarachnoid hemorrhage.

Wang JX, Hou Y, Ruan SP, Wang J, Hu XM.

Peptides. 2013 Dec;50:8-12. doi: 10.1016/j.peptides.2013.09.016. Epub 2013 Oct 9.

PMID:
24120704
10.

The outcomes of early aneurysm repair in World Federation of Neurosurgical Societies grade V subarachnoid haemorrhage patients with emphasis on those presenting with a Glasgow Coma Scale score of 3.

Inamasu J, Nakae S, Ohmi T, Kogame H, Kawazoe Y, Kumai T, Tanaka R, Wakako A, Kuwahara K, Ganaha T, Hirose Y.

J Clin Neurosci. 2016 Nov;33:142-147. doi: 10.1016/j.jocn.2016.03.035. Epub 2016 Jul 19.

PMID:
27450281
11.
12.

Increased GFAP and S100beta but not NSE serum levels after subarachnoid haemorrhage are associated with clinical severity.

Vos PE, van Gils M, Beems T, Zimmerman C, Verbeek MM.

Eur J Neurol. 2006 Jun;13(6):632-8.

PMID:
16796588
13.

Atorvastatin decreases computed tomography and S100-assessed brain ischemia after subarachnoid aneurysmal hemorrhage: a comparative study.

Sanchez-Peña P, Nouet A, Clarençon F, Colonne C, Jean B, Le Jean L, Fonfrede M, Aout M, Vicaut E, Puybasset L.

Crit Care Med. 2012 Feb;40(2):594-602. doi: 10.1097/CCM.0b013e31822f05e7.

PMID:
21926584
14.

Preoperative and postoperative predictors of long-term outcome after endovascular treatment of poor-grade aneurysmal subarachnoid hemorrhage.

Zhao B, Yang H, Zheng K, Li Z, Xiong Y, Tan X, Zhong M; AMPAS Study Group.

J Neurosurg. 2017 Jun;126(6):1764-1771. doi: 10.3171/2016.4.JNS152587. Epub 2016 Jul 1.

PMID:
27367238
15.

Prognosis Predicting Score for Endovascular Treatment of Aneurysmal Subarachnoid Hemorrhage: A Risk Modeling Study for Individual Elderly Patients.

Duan G, Yang P, Li Q, Zuo Q, Zhang L, Hong B, Xu Y, Zhao W, Liu J, Huang Q.

Medicine (Baltimore). 2016 Feb;95(7):e2686. doi: 10.1097/MD.0000000000002686.

16.

Glasgow Coma Scale in the prediction of outcome after early aneurysm surgery.

Gotoh O, Tamura A, Yasui N, Suzuki A, Hadeishi H, Sano K.

Neurosurgery. 1996 Jul;39(1):19-24; discussion 24-5.

PMID:
8805136
17.

Predictors of 1-year outcome after coiling for poor-grade subarachnoid aneurysmal hemorrhage.

Pereira AR, Sanchez-Peña P, Biondi A, Sourour N, Boch AL, Colonne C, Lejean L, Abdennour L, Puybasset L.

Neurocrit Care. 2007;7(1):18-26.

PMID:
17657653
18.

Timing of aneurysm surgery in subarachnoid haemorrhage--an observational study in The Netherlands.

Nieuwkamp DJ, de Gans K, Algra A, Albrecht KW, Boomstra S, Brouwers PJ, Groen RJ, Metzemaekers JD, Nijssen PC, Roos YB, Tulleken CA, Vandertop WP, van Gijn J, Vos PE, Rinkel GJ.

Acta Neurochir (Wien). 2005 Aug;147(8):815-21. Epub 2005 Jun 16.

PMID:
15944811
19.

Predictive model for patients with poor-grade subarachnoid haemorrhage in 30-day observation: a 9-year cohort study.

Szklener S, Melges A, Korchut A, Zaluska W, Trojanowski T, Rejdak R, Rejdak K.

BMJ Open. 2015 Jun 12;5(6):e007795. doi: 10.1136/bmjopen-2015-007795.

20.

Cerebrospinal fluid creatine kinase-BB isoenzyme activity and outcome after subarachnoid hemorrhage.

Coplin WM, Longstreth WT Jr, Lam AM, Chandler WL, Mayberg TS, Fine JS, Winn HR.

Arch Neurol. 1999 Nov;56(11):1348-52.

PMID:
10555654

Supplemental Content

Support Center